Surrogacy Market (2026 - 2035)

Rising Infertility Prevalence

The World Health Organization estimates that around 17.5% of the world’s adult population suffers from infertility. Environmental and lifestyle changes exacerbate this ongoing public health problem. So in places like South Korea, the government has spent a lot of money on fertility support, including free or very cheap IVF therapy, which keeps the surrogacy market going when the first round doesn’t work.

Delayed Parenthood and Changing Demographics

In the OECD countries, the average age of first-time mothers has steadily increased and is now about 30 years in several developed economies. This tendency to become parents later in life is the fundamental reason for assisted reproduction. With the increase in biological age, clinical procedures are more relied upon, eventually growing the pool of candidates for surrogacy.

Legislative Liberalization

Legislative frameworks are increasingly being developed to offer legal clarity for reproductive agreements. For example, Thailand is in the process of revising its Assisted Reproductive Technologies Act to provide access to international couples, perhaps. These changing legislation changes lower the legal risks for intended parents, directly boosting the growth and stability of cross-border surrogacy market activities globally.

AI-Driven Reproductive Technology

Integrating artificial intelligence into fertility care is transforming clinical outcomes. Studies indicate that AI-assisted embryo selection can improve IVF pregnancy rates by up to 20% compared to conventional methods. By enhancing precision in embryo viability assessment, these technologies reduce the number of failed cycles required, improving overall cost-efficiency and increasing accessibility for prospective parents.

As with driver estimates, the restraint impact percentages below are directional indicators rather than precise CAGR offsets.

Regulatory Fragmentation

European nations exhibit extreme legislative divergence, ranging from total bans—such as Italy’s 2024 classification of surrogacy as a “universal crime”—to restricted altruistic frameworks in countries like the UK. This fragmentation creates significant legal uncertainty for an estimated 450 million residents, forcing intended parents into high-risk cross-border arrangements while impeding regional market harmonization.

High All-In Program Costs

Gestational surrogacy remains a high-capital endeavor, with total costs in the United States currently ranging from USD 150,000 to over USD 220,000 for standard journeys. These financial barriers drive price-sensitive intended parents toward lower-cost international destinations, where programs often range from USD 50,000 to USD 80,000, creating a two-tiered global market defined by economic accessibility.

Ethical and Safeguarding Concerns

Surrogacy faces intense scrutiny regarding human rights, with the UN Special Rapporteur on violence against women and girls calling for international abolition due to exploitation risks. In 2026, the Hague Conference indefinitely suspended its work on a cross-border framework, while a growing coalition of UN states now advocates for a global moratorium on all arrangements.

Employer-Sponsored Fertility Benefits

Major global corporations are increasingly integrating comprehensive surrogacy support into their employee benefits packages to foster workplace inclusivity. By 2026, leading firms will have standardized support levels, with some providing upwards of USD 150,000 for surrogacy and related IVF procedures. This corporate trend significantly lowers financial barriers, enabling a wider demographic of employees to pursue family-building journeys.

Digital Matching Platforms and Marketplace Models

Digital fertility health platforms are revolutionizing reproductive care by utilizing data-driven models to streamline the coordination of surrogacy journeys. By integrating telehealth, automated legal document management, and centralized clinical monitoring, these tools reduce administrative timelines from approximately 18 months to under 10. These efficiencies improve accessibility and patient outcomes through enhanced service delivery and transparency.

Emerging Markets in Southeast Asia and Latin America

Nations such as Colombia are refining their legal frameworks to provide structured, transparent environments for assisted reproduction. By mandating insurance protections and clarifying parental rights, these jurisdictions are emerging as key hubs for international intended parents. This shift toward regulated, cost-competitive models is expected to attract significant global patient volume and investment into regional reproductive infrastructure.

Genetic Screening and Personalized Reproductive Medicine

Advancements in next-generation sequencing and expanded carrier screening allow intended parents to identify genetic risks before conception with greater precision. By integrating these screening panels with personalized medication protocols, clinics can optimize embryo selection and pregnancy outcomes. This shift toward highly individualized, evidence-based care increases clinical success rates and provides greater confidence to prospective parents.

Insurance Product Innovation

The development of specialized insurance products is mitigating the financial unpredictability inherent in surrogacy. New policies now cover contingencies such as failed transfers, pregnancy complications, and neonatal intensive care unit stays. By bundling these risks, insurers are providing critical financial security for both surrogates and intended parents, unlocking demand from risk-averse individuals previously deterred by potential costs.

North America

The United States remains the anchor of the global Surrogacy Market, with California, Nevada, and Connecticut operating as primary hubs due to pre-birth parentage order availability. The American Bar Association's 2024 Surrogacy Law Survey identified 14 additional states that enacted or amended surrogacy-enabling statutes between 2020 and 2024, gradually expanding the domestic addressable market . Canada's altruistic framework limits domestic growth, but Canadian intended parents increasingly pursue arrangements in the U.S. and abroad.

Europe

Ukraine and Greece serve as Europe's two principal surrogacy destinations. Despite disruptions from the Russia-Ukraine conflict, Ukrainian clinics have partially relocated to western Ukraine and neighboring countries, maintaining service continuity. The UK Law Commission's 2023 surrogacy reform report recommended a new pathway granting intended parents legal parentage at birth, a change that—if enacted—would transform the UK Surrogacy Market landscape [19].

Asia-Pacific

Asia-Pacific's Surrogacy Market growth is anchored by dual dynamics: high domestic infertility rates and the region's role as a cost-effective destination for international intended parents. India's 2021 Surrogacy (Regulation) Act restricted commercial surrogacy but created a regulated altruistic pathway that still attracts significant volumes [20]. Thailand's revised legislation has made it the fastest-growing ASEAN destination, while South Korea's government allocated KRW 3.6 trillion (USD 2.7 billion) toward fertility support programs through 2027 [11].

South America

Colombia's constitutional court rulings have created a de facto permissive environment for surrogacy arrangements, and the country's healthcare infrastructure supports high-quality IVF programs at a fraction of U.S. costs. Brazil permits altruistic surrogacy among family members up to the fourth degree of kinship, constraining commercial growth but sustaining steady volumes within the Surrogacy Market.

Middle East & Africa

South Africa stands out in this region with a structured legal framework under the Children's Act that permits surrogacy with prior High Court confirmation. The UAE, while not permitting surrogacy domestically, serves as a coordination hub where agencies connect Gulf-based intended parents with programs in the U.S., Greece, and Georgia.

By Type

Gestational surrogacy dominates the Surrogacy Market because it eliminates the surrogate's genetic relationship with the child, simplifying parental rights adjudication in virtually every jurisdiction that permits surrogacy. Intended parents—and their legal advisors—overwhelmingly prefer this model. Traditional surrogacy, while a smaller segment, is gaining traction in regions where IVF access is limited or cost-prohibitive, offering a lower barrier to entry that appeals to single intended parents and those in emerging markets.

By Compensation Model

Commercial arrangements lead the Surrogacy Market because financial compensation expands the available surrogate pool and reduces wait times. Altruistic surrogacy, mandated in countries such as the United Kingdom, Canada, and India, is growing as these markets formalize their regulatory frameworks and attract domestic demand that was previously served abroad.

By Technology

IVF remains the cornerstone technology for the Surrogacy Market, as it allows genetic contribution from both intended parents (or selected donors) and supports preimplantation genetic testing. Rising success rates—now exceeding 55% per transfer in leading clinics—continue to reinforce IVF's dominance.

By Intended Parent Type

The segment of heterosexual couples is dominating the market, and the segment of same-sex couples is accelerating at the fastest rate, growing at a 20.8% CAGR (2026–2035).

By Service Provider

The surrogacy service providers categorize the market. Fertility Centers dominate the landscape, holding a 67.5% market share as of 2025. Meanwhile, Surrogacy Agencies represent the fastest-growing segment, projected to experience a 20.7% CAGR between 2026 and 2035, driven by their specialized coordination services.

By Arrangement Geography

Cross-border surrogacy is the fastest-growing arrangement category within the Surrogacy Market, as intended parents in countries that ban or restrict surrogacy seek legal and affordable programs elsewhere. Eastern Europe, the Caucasus, and Southeast Asia are the primary receiving regions, while intended parents from Western Europe, East Asia, and the Middle East constitute the dominant outbound flows.

The Surrogacy Market is highly fragmented, with an estimated HHI below 400 and no single player commanding more than 8% of global revenue. The top five players collectively account for roughly 18–24% of the market, reflecting the localized nature of surrogacy services and the influence of jurisdiction-specific legal requirements. Competition centers on program success rates, surrogate welfare standards, legal expertise, and geographic reach.